CRO Alliance Pharma’s Executive Team Grows by Four, Supporting Bioanalytical and CMC Testing Expansions

22 September 2022 | Thursday | News


Alliance Pharma (Alliance), a global leader in bioanalytical, DMPK and CMC testing services in the pharmaceutical and biopharmaceutical industry, has grown their leadership team by four, bringing on board a new Chief Operating Officer (COO), Chief Commercial Officer (CCO), Chief Financial Officer (CFO), and Chief People Officer (CPO)
Alliance Pharma grows leadership by four (from left to right): Jean Pierre (JP) Boutrand, COO; Vito Saccente, CCO; Glenn Weber, CFO; Susan Woolley, CPO.

Alliance Pharma grows leadership by four (from left to right): Jean Pierre (JP) Boutrand, COO; Vito Saccente, CCO; Glenn Weber, CFO; Susan Woolley, CPO.

These leaders will support continued global expansion, which includes Alliance’s recent acquisition of U.K.-based Drug Development Solutions (DDS) from LGC and new bioanalytical laboratory opening in Australia in November.

 

Jean Pierre (JP) Boutrand, DVM, M.S., COO, is leading Alliance’s global operational strategy in the preclinical, clinical bioanalysis, and CMC business lines. He has more than 25 years of executive operation, commercial, and corporate experience in life sciences laboratory operations, digital technologies, medical device innovation, and pharmaceutical development, as well as designing and implementing improvements for effective teams and customer satisfaction.

 

Vito Saccente is Alliance’s new CCO, bringing 25+ years of sales leadership experience in the life sciences CRO industry, including all aspects of nonclinical and clinical testing for vaccines, small molecules, and large molecules. He also has experience in supporting formulation development, manufacturing, and analytical testing of pharmaceutical products, along with contributing to corporate strategy for mergers and acquisitions. At Alliance, Saccente will be focused on the global restructuring of the commercial process and organization structure, activities that will further improve the customer experience.

 

Glenn Weber, CFO, has over 35 years’ experience in corporate finance across multiple industries. His early career included financial analysis and corporate development in the tire industry, followed by the global chemical industry. Most recently, Weber was CFO of several private equity-sponsored companies.

 

Susan Woolley, CPO, is driving employee-centric initiatives that optimize Alliance Pharma’s success through development programs and engagement. She has 20 years of experience in change management, succession planning, talent development, coaching leaders, improving synergy and effectiveness, and inspiring results across all levels of an organization.

 

“These leaders bring years of specialized expertise and leadership for our team and our scientists,” said Alliance CEO Patrick Bennett. “Alliance is growing rapidly, and these experienced leaders ensure continued growth and support for our customers’ drug discovery and development programs.”

 

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close